• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义高血压介入治疗反应者的新方法:来自SPYRAL HTN-OFF和HTN-ON MED试验的见解

Novel approaches to define responders to interventional treatment in hypertension: insights from the SPYRAL HTN-OFF and HTN-ON MED trials.

作者信息

Schmieder Roland E, Hettrick Douglas A, Böhm Michael, Kandzari David E, Kario Kazuomi, Mahfoud Felix, Tsioufis Konstantinos, Weber Michael A, Esler Murray D, Townsend Raymond R

机构信息

University Hospital Erlangen, Erlangen, Germany.

Medtronic, Santa Rosa, CA, USA.

出版信息

Hypertens Res. 2025 Jan;48(1):327-335. doi: 10.1038/s41440-024-01949-4. Epub 2024 Nov 14.

DOI:10.1038/s41440-024-01949-4
PMID:39543413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11700838/
Abstract

Multiple sham-controlled clinical trials have demonstrated significant reductions in both office and 24-h blood pressure (BP) following radiofrequency renal denervation (RDN) in the uncontrolled hypertension population. Notably, the blood pressure response varies widely within individual participants, thus showing a clinical need to identify potential RDN "responders" prior to the procedure. Despite multiple analytic efforts, no single parameter, aside from baseline blood pressure, has been consistently associated with BP reduction following RDN. However, this failure may be due to limitations in empiric definitions of responders. Indeed, commonly applied responder definitions based on the difference between two point-in-time BP measurements are fraught due to visit-to-visit variability in office and 24-h blood pressure endpoints. Several factors should be considered to develop a more clinically useful operational definition of procedural response including relative changes in office and 24-h BP, consideration of the temporal response to RDN, as well as adjustment for baseline BP. The current evidence may provide incentives for future expert consensus to precisely define responders to hypertension treatments.

摘要

多项假手术对照临床试验表明,在未控制的高血压人群中,经导管肾去交感神经术(RDN)后诊室血压和24小时血压(BP)均显著降低。值得注意的是,个体参与者的血压反应差异很大,因此表明在手术前有临床需求来识别潜在的RDN“反应者”。尽管进行了多项分析,但除了基线血压外,没有单一参数与RDN后的血压降低始终相关。然而,这种失败可能是由于反应者经验性定义的局限性。事实上,基于两个时间点血压测量值差异的常用反应者定义存在缺陷,因为诊室血压和24小时血压终点的就诊间变异性较大。为了制定更具临床实用性的手术反应操作定义,应考虑几个因素,包括诊室血压和24小时血压的相对变化、对RDN的时间反应以及对基线血压的调整。目前的证据可能会促使未来专家达成共识,以精确界定高血压治疗的反应者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4e/11700838/99e805837cc6/41440_2024_1949_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4e/11700838/00e7a53fe108/41440_2024_1949_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4e/11700838/7d05eaed4981/41440_2024_1949_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4e/11700838/992386f27cc8/41440_2024_1949_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4e/11700838/4bec4e85bf59/41440_2024_1949_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4e/11700838/99e805837cc6/41440_2024_1949_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4e/11700838/00e7a53fe108/41440_2024_1949_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4e/11700838/7d05eaed4981/41440_2024_1949_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4e/11700838/992386f27cc8/41440_2024_1949_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4e/11700838/4bec4e85bf59/41440_2024_1949_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af4e/11700838/99e805837cc6/41440_2024_1949_Fig5_HTML.jpg

相似文献

1
Novel approaches to define responders to interventional treatment in hypertension: insights from the SPYRAL HTN-OFF and HTN-ON MED trials.定义高血压介入治疗反应者的新方法:来自SPYRAL HTN-OFF和HTN-ON MED试验的见解
Hypertens Res. 2025 Jan;48(1):327-335. doi: 10.1038/s41440-024-01949-4. Epub 2024 Nov 14.
2
Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MED.不同患者群体肾去神经术后降压药物变化的影响:SPYRAL HTN-ON MED 试验
Hypertension. 2024 May;81(5):1095-1105. doi: 10.1161/HYPERTENSIONAHA.123.22251. Epub 2024 Feb 5.
3
Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence.肾去神经术治疗高血压:当前的科学和临床证据。
JACC Cardiovasc Interv. 2019 Jun 24;12(12):1095-1105. doi: 10.1016/j.jcin.2019.02.050.
4
Ambulatory Blood Pressure Monitoring to Predict Response to Renal Denervation: A Post Hoc Analysis of the RADIANCE-HTN SOLO Study.动态血压监测预测肾去神经术反应:RADIANCE-HTN SOLO 研究的事后分析。
Hypertension. 2021 Feb;77(2):529-536. doi: 10.1161/HYPERTENSIONAHA.120.16292. Epub 2020 Dec 28.
5
A novel, proof-of-concept radiofrequency renal denervation strategy to improve procedural efficiency: 12-month results from the SPYRAL DYSTAL pilot study.一种新的、概念验证的射频肾去神经治疗策略,可提高手术效率:SPYRAL DYSTAL 先导研究的 12 个月结果。
Cardiovasc Revasc Med. 2024 Nov;68:30-36. doi: 10.1016/j.carrev.2024.04.005. Epub 2024 Apr 10.
6
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications.抗高血压药物治疗患者的肾脏去神经术的安全性和疗效。
J Am Coll Cardiol. 2023 Nov 7;82(19):1809-1823. doi: 10.1016/j.jacc.2023.08.045.
7
Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.对接受肾去神经术治疗高血压的患者在24个月内逐次进行的个体患者门诊和动态血压测量。
Int J Cardiol. 2015 Feb 15;181:96-101. doi: 10.1016/j.ijcard.2014.12.001. Epub 2014 Dec 4.
8
Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled Hypertension.心率对高血压未控制患者肾去神经治疗结局的影响。
J Am Coll Cardiol. 2021 Sep 7;78(10):1028-1038. doi: 10.1016/j.jacc.2021.06.044.
9
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial.在不使用抗高血压药物的情况下基于导管的肾脏去神经术的疗效(SPYRAL HTN-OFF MED Pivotal):一项多中心、随机、假对照试验。
Lancet. 2020 May 2;395(10234):1444-1451. doi: 10.1016/S0140-6736(20)30554-7. Epub 2020 Mar 29.
10
Renal Denervation in the treatment of Resistant Hypertension.肾去神经术治疗耐药性高血压。
Med J Malaysia. 2021 Nov;76(6):893-897.

引用本文的文献

1
Renal Denervation After USA FDA Approval: An Update from an Interventional Cardiologist's Perspective.美国食品药品监督管理局(FDA)批准后的肾去神经支配:介入心脏病专家视角的最新进展
J Clin Med. 2025 May 19;14(10):3554. doi: 10.3390/jcm14103554.

本文引用的文献

1
Response of Blood Pressure to Renal Denervation Is Not Associated With Genetic Variants.血压对肾去神经支配的反应与基因变异无关。
Hypertension. 2025 Jan;82(1):118-125. doi: 10.1161/HYPERTENSIONAHA.124.23393. Epub 2024 Nov 21.
2
SCAI Position Statement on Renal Denervation for Hypertension: Patient Selection, Operator Competence, Training and Techniques, and Organizational Recommendations.SCAI关于高血压肾去神经支配的立场声明:患者选择、术者能力、培训与技术以及组织建议
J Soc Cardiovasc Angiogr Interv. 2023 Aug 21;2(6Part A):101121. doi: 10.1016/j.jscai.2023.101121. eCollection 2023 Nov-Dec.
3
Blood pressure reduction after renal denervation in patients with or without chronic kidney disease.
慢性肾病患者和非慢性肾病患者肾去神经支配后的血压降低情况。
Clin Kidney J. 2023 Nov 17;17(1):sfad237. doi: 10.1093/ckj/sfad237. eCollection 2024 Jan.
4
Agreement Between Guideline Thresholds Using an "All-in-One" Device to Measure Office, Home, and Ambulatory Blood Pressures.使用“一体机”设备测量诊室、家庭和动态血压的指南阈值之间的一致性。
J Am Heart Assoc. 2023 Dec 5;12(23):e030992. doi: 10.1161/JAHA.123.030992. Epub 2023 Dec 1.
5
Comparison between visit-to-visit office and 24-h blood pressure variability in treated hypertensive patients.在接受治疗的高血压患者中,就诊间血压变异性与 24 小时血压变异性的比较。
J Hypertens. 2024 Jan 1;42(1):161-168. doi: 10.1097/HJH.0000000000003582. Epub 2023 Oct 9.
6
Generalized Pairwise Comparisons to Assess Treatment Effects: JACC Review Topic of the Week.广义成对比较评估治疗效果:JACC 综述专题的一周。
J Am Coll Cardiol. 2023 Sep 26;82(13):1360-1372. doi: 10.1016/j.jacc.2023.06.047.
7
Outcomes Following Radiofrequency Renal Denervation According to Antihypertensive Medications: Subgroup Analysis of the Global SYMPLICITY Registry DEFINE.根据降压药物对射频肾动脉去神经术治疗后结果的影响:SYMPLICITY 全球注册研究 DEFINE 亚组分析。
Hypertension. 2023 Aug;80(8):1759-1770. doi: 10.1161/HYPERTENSIONAHA.123.21283. Epub 2023 Jun 15.
8
Quantifying Blood Pressure Visit-to-Visit Variability in the Real-World Setting: A Retrospective Cohort Study.量化真实环境下的血压随访间变异性:一项回顾性队列研究。
Circ Cardiovasc Qual Outcomes. 2023 Apr;16(4):e009258. doi: 10.1161/CIRCOUTCOMES.122.009258. Epub 2023 Mar 8.
9
Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial.血管内超声肾脏去神经治疗高血压:RADIANCE II 随机临床试验。
JAMA. 2023 Feb 28;329(8):651-661. doi: 10.1001/jama.2023.0713.
10
Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).成人高血压管理中的肾去神经支配。欧洲心脏病学会高血压委员会和欧洲经皮心血管介入协会(EAPCI)的临床共识声明。
Eur Heart J. 2023 Apr 17;44(15):1313-1330. doi: 10.1093/eurheartj/ehad054.